Form D · Pharmaceuticals
Anagin, Inc.
Indianapolis, IN · CIK 0001679399
Offering snapshot reported Jun 29, 2018 · SEC filing
- Reported sold
- $1.31M Offering amount: $1.4M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2018 | Initial | $1,308,688 | No comparison | 20 | SEC filing |
| Apr 25, 2017 | Amendment | $3,050,000 | $2,100,000vs Jul 12, 2016 | 23 | SEC filing |
| Jul 12, 2016 | Initial | $950,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315793
Source: Form D, filed Jun 29, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nora Doherty | Director |
| Frank French | Director |
| Jaswant Gidda | Director, Executive |
| Yvonne Lai | Executive |
| James Schulz | Executive |
| Anantha Shekhar | Director |
| Derek Small | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Indiana Ctr For Biomedic. Innov. Noyes P 5 Th Floor, Ste E504, 1800 N Capitol Ave.
Indianapolis, IN, 46202
Indianapolis, IN, 46202